Abby is a highly experienced non-executive board chair, director, audit and risk specialist and leader in governance and innovation.
An adviser, founder and investor in numerous Australian medical and tech startups over the past 25 years, Abby’s areas of expertise span healthcare and biomedical translation, including commercialisation as well as insurance, deeptech, water and sewage and advanced manufacture.
She currently chairs the medical deeptech company DatChem and the Centre for Sovereign Manufacturing of Composite Materials, is a non-executive director of the neonatal medtech company ResusRight and serves on the Advisory Board of World Data Exchange.
As an epidemiologist, her own research has concentrated in applied public health and chronic disease epidemiology, including the misuse of over-the-counter paediatric medication, the physical and psychosocial impacts of social isolation among older people, and translation of health policy into programs in Jamaica West Indies and Senegal.
She is an expert in hospital Public-Private Partnerships, and has advised The World Bank, UNICEF, the IFC, AusAID and USAID. She has co-founded 3 medical device companies, and most recently has developed a digital social enterprise to help families manage the ageing journey. She has worked in over 24 countries, often in remote and challenging environments.
Abby is a member of our Audit and Risk Management Committee and a nominee director of The Sydney Children’s Hospital Network to the Board of Luminesce Alliance.
She brings to Luminesce Alliance extensive expertise and experience across risk innovation, organisational culture, data and data analytics, geographically dispersed units, and highly regulated industries.
Sydney Children’s Hospital Network
State Insurance Regulatory Agency
ResusRight Pty Ltd
Ballet Without Borders